{
    "title": "Molecular Partners jumps after Novartis deal for potential COVID-19 drugs",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8887497/Novartis-Molecular-Partners-ink-potential-230-mln-deal-COVID-19-candidates.html",
    "date": "2020-10-28",
    "keywords": [
        "novartis",
        "drug",
        "deal",
        "mp0420",
        "miller",
        "payment",
        "eye",
        "development",
        "wednesday",
        "biotech",
        "companys",
        "milestone",
        "royalty",
        "gmt",
        "yeartodate",
        "drop",
        "motion",
        "part",
        "slide",
        "tuesday",
        "mp0423",
        "half",
        "government",
        "august",
        "pandemic",
        "level",
        "virus",
        "addition",
        "hydroxychloroquine",
        "president",
        "endorsement",
        "covid19",
        "drugdiscovery",
        "programme",
        "pair",
        "clinic",
        "year",
        "entry",
        "field",
        "lustre",
        "abicipar",
        "partnership",
        "food",
        "administration",
        "approval",
        "reporting",
        "john",
        "michael",
        "mark",
        "potter"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}